Harbin Medisan Pharmaceutical Co Ltd (002900) — Cash Flow-to-Debt Ratio
Harbin Medisan Pharmaceutical Co Ltd (002900) has a Cash Flow-to-Debt Ratio of -0.01x as of September 2025, meaning its operating cash flow of CN¥-15.53 Million could theoretically repay 0% of its total liabilities (CN¥1.70 Billion) in one year. See 002900 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Harbin Medisan Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Harbin Medisan Pharmaceutical Co Ltd across 13 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Harbin Medisan Pharmaceutical Co Ltd.
Annual Cash Flow-to-Debt Ratio for Harbin Medisan Pharmaceutical Co Ltd (2012–2024)
Year-by-year debt coverage analysis for Harbin Medisan Pharmaceutical Co Ltd. Check Harbin Medisan Pharmaceutical Co Ltd (002900) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.02x | CN¥30.69 Million | CN¥1.64 Billion | ▼ -32.0% |
| 2023 | 0.03x | CN¥35.69 Million | CN¥1.29 Billion | ▼ -76.7% |
| 2022 | 0.12x | CN¥144.64 Million | CN¥1.22 Billion | ▲ +994.2% |
| 2021 | -0.01x | CN¥-12.53 Million | CN¥949.04 Million | ▼ -102.5% |
| 2020 | -0.01x | CN¥-4.51 Million | CN¥691.18 Million | ▼ -101.7% |
| 2019 | 0.39x | CN¥320.14 Million | CN¥820.44 Million | ▼ -27.4% |
| 2018 | 0.54x | CN¥292.46 Million | CN¥543.78 Million | ▼ -16.1% |
| 2017 | 0.64x | CN¥223.46 Million | CN¥348.80 Million | ▼ -0.8% |
| 2016 | 0.65x | CN¥231.18 Million | CN¥358.01 Million | ▲ +4.5% |
| 2015 | 0.62x | CN¥200.85 Million | CN¥324.95 Million | ▲ +92.0% |
| 2014 | 0.32x | CN¥116.31 Million | CN¥361.30 Million | ▼ -5.1% |
| 2013 | 0.34x | CN¥167.10 Million | CN¥492.63 Million | ▲ +3.6% |
| 2012 | 0.33x | CN¥123.22 Million | CN¥376.29 Million | — |